Trastuzumab deruxtecan
Trastuzumab deruxtecan (T-DXd) is an antibody-active molecule conjugate (ADC) with anticancer and antitumor activity, which is composed of a monoclonal antibody targeting human epidermal growth factor receptor 2 (HER2) coupled to a topoisomerase I inhibitor (DXd) . Trastuzumab deruxtecan has an improved effect on the treatment of HER2-positive breast cancer and gastric cancer.
Product Specifications
CAS Number
1826843-81-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
Approximately 45.42 kDa
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Antibody-Drug Conjugates (ADCs)
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![5- (chloromethyl) -1-[4- (difluoromethoxy) phenyl]-1H-1,2,3,4-tetrazole](https://cdn.genprice.uk/genprice/genprice5.png)
sc-350244A 1 g
5- (chloromethyl) -1-[4- (difluoromethoxy) phenyl]-1H-1,2,3,4-tetrazole
Ask
View Details 
